TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1/20/23 16:34 | 1/18/23 | MYOV | Myovant Sciences Ltd. | CA | Health | Drug | Pharmaceutical Preparations | Merendino Lauren | CA | O | Chief Co | S | -54 | 26.89 | 0 | -2 | -1 | 170 | D | ||||||||||||||
10/20/22 16:54 | 10/18/22 | MYOV | Myovant Sciences Ltd. | CA | Health | Drug | Pharmaceutical Preparations | Merendino Lauren | CA | O | Chief Co | S | -43 | 25.20 | 0 | -2 | -1 | 172 | D | ||||||||||||||
7/20/22 16:37 | 7/18/22 | MYOV | Myovant Sciences Ltd. | CA | Health | Drug | Pharmaceutical Preparations | Merendino Lauren | CA | O | Chief Co | S | -22 | 12.87 | 0 | -2 | -1 | 173 | D | ||||||||||||||
4/21/22 16:25 | 4/19/22 | MYOV | Myovant Sciences Ltd. | CA | Health | Drug | Pharmaceutical Preparations | Merendino Lauren | CA | O | Chief Co | S | -74 | 10.45 | 0 | -7 | -4 | 175 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |